Ritu Aneja

This inventor holds 11 USPTO granted patents and 7 published patent applications. Top assignees: Emory University, Novazoi Theranostics, The Georgia State University Research Foundation, Inc.. Active years: 2013-2026.

USPTO Granted Patents = 11 (Patent Applications = 7)

% Patents Active = 72.7

Average Co-Inventor Count = 2.4

ph-index = 1

Forward Citations = 2(Granted Patents)

Company Filing History:

The Georgia State University Research Foundation, Inc.

patents

4. 1 out of 1

Metanoi Therapeutics, Inc.

patent

where one patent can have more than one assignee

Years Active: 2013-2026

Loading Chart...

11 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12650430 - Quantitative centrosomal amplification score to predict local recurrence of ductal carcinoma in situ (2026-06-09),

2. 11607421 - Ethanolamine-based lipid biosynthetic compounds, method of making and use thereof (2023-03-21),

3. 10242153 - Method for determining the risk profile of neoplastic tissue (2019-03-26),

4. 10213448 - Ethanolamine-based lipid biosynthetic compounds, method of making and use thereof (2019-02-26),

5. 9857354 - Compositions and methods for prognosis and treatment of neoplasm (2018-01-02),

6. 9589100 - Method for determining the risk profile of neoplastic tissue (2017-03-07),

7. 8889705 - Noscapine analogs and their use in treating cancers (2014-11-18),

8. 8841317 - Noscapine and analogs and methods related thereto (2014-09-23),

9. 8815835 - 9-aminonoscapine and its use in treating cancers, including drug-resistant cancers (2014-08-26),

10. 8426398 - Conjugates of noscapine and folic acid and their use in treating cancer (2013-04-23),

11. 8394957 - 9-aminonoscapine and its use in treating cancers, including drug-resistant cancers (2013-03-12),

Title: Ritu Aneja: Innovator in Cancer Treatment

Introduction

Ritu Aneja is a prominent inventor based in Lilburn, GA (US), known for her significant contributions to the field of cancer treatment. With a total of 11 patents, she has developed innovative methods and compositions that aim to improve patient outcomes in oncology.

Latest Patents

Among her latest patents is an invention titled "Ethanolamine-based lipid biosynthetic compounds, method of making and use thereof." This method discloses a novel approach for treating cancer by administering a pharmaceutical composition that includes monoethanolamine or its derivatives. The composition is designed for various forms of administration, including oral and intravenous routes. Another notable patent is the "Method for determining the risk profile of neoplastic tissue," which outlines a systematic approach to compute the risk profile of tumor tissues. This method involves analyzing tumor samples to assess centrosome amplification, providing valuable insights into the severity and prognosis of cancer.

Career Highlights

Ritu has worked with esteemed organizations such as Emory University and Novazoi Theranostics, where she has honed her expertise in cancer research and therapeutic development. Her work has been instrumental in advancing the understanding of cancer biology and treatment methodologies.

Collaborations

Throughout her career, Ritu has collaborated with notable professionals, including Harish C Joshi and Surya N Vangapandu. These collaborations have enriched her research and contributed to the development of her innovative patents.

Conclusion

Ritu Aneja's work exemplifies the impact of innovation in the medical field, particularly in cancer treatment. Her patents reflect a commitment to improving patient care through scientific advancement.